Bluejay Diagnostics (BJDX) EBIAT (2022 - 2023)
Historic EBIAT for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to -$2.8 million.
- Bluejay Diagnostics' EBIAT fell 4521.02% to -$2.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$10.7 million, marking a year-over-year change of. This contributed to the annual value of -$7.7 million for FY2024, which is 2246.45% up from last year.
- Bluejay Diagnostics' EBIAT amounted to -$2.8 million in Q2 2023, which was down 4521.02% from -$2.5 million recorded in Q1 2023.
- In the past 5 years, Bluejay Diagnostics' EBIAT ranged from a high of -$1.9 million in Q2 2022 and a low of -$3.0 million during Q3 2022